What are the most common side effects from Bevacizumab +Temozolomide for High-Grade Glioma?
In a multi-drug regimen, each medication has unique side effects. When these medicines are given together, drug-related side effects reported in clinical studies give the best estimate of what to expect. In clinical studies, the most commonly reported side effects of bevacizumab + temozolomide are shown here.
Although not reported in the original Bevacizumab + Temozolomide clinical trial, other possible side effects include, but are not limited to, nausea and vomiting, constipation, diarrhea, and mild hair loss.
On average, 8% of patients discontinue treatment due to unacceptable side effects.
Importantly, not all people who experience a side effect from bevacizumab + temozolomide will experience it in the same way. It may be mild in some or severe in others, depending upon the individual. Everybody is different. Additionally, side effects may vary over time. For some, side effects may be a reason to delay or switch treatment, reduce the dose, or avoid treatment with a certain medication altogether.
Side effects may be treatable when they occur or preventable by taking certain medications before they happen. When medications are taken to prevent a problem, this is known as prophylaxis, or "prophy" for short.
After starting treatment with bevacizumab + temozolomide, be sure to come back and watch all of the side effect videos shown below. Each of these videos contain valuable information about side effect management that will hopefully help you to both feel better and stay out of the hospital.
Watch videos on common Bevacizumab + Temozolomide therapy side effects below